Thursday 19 November 2026 Sign in / SubscribeFree daily emailMarket analysisEnterprise solutionsVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Manufacturing & supply

UK regulator's latest device safety notices touch cardiac, diabetes, imaging and lab-testing makers

The MHRA's weekly list names dozens of medtech and diagnostics suppliers, but it does not say what went wrong or whether any product is affected commercially.

10 Nov 2026 · MHRA alerts · Regulator

A number of well-known medical device and diagnostics companies appear in the latest weekly Field Safety Notice list from the UK's Medicines and Healthcare products Regulatory Agency, published on 10 November 2026. The list gives no sign of any commercial consequence, such as stop-sale orders, supply interruptions or financial exposure. It does not describe the underlying problems at all.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on CompePharma and VigiEye
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official record: MHRA alerts ↗

Written by CompePharma's editorial system from the official record. AI-assisted; check the source before acting. Not investment advice.

More Manufacturing & supplyAll →